Julio Grados

Julio Grados

Auto-generated profile, based on publicly available information

Julio Grados


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2026 in Anales de la Facultad de Medicina
Verified
Journal Article
Open access
CLCesar I. León-Vega
Cesar I. León-Vega
SGSergio Goicochea-Lugo
Sergio Goicochea-Lugo
JGJulio Grados
Julio Grados
KLKaren Lalupu
Karen Lalupu
KPKatherine Palacios
Katherine Palacios
RTRaúl Timaná-Ruiz
Raúl Timaná-Ruiz
Introduction. This article summarizes the clinical practice guideline (CPG) for colorectal cancer (CRC) screening in primary care. Objective. To provide evidence-based recommendations on the use of CRC screening methods in individuals aged 18 years and older. Methods. A guideline development group (GDG), composed of specialist physicians and methodologists, formulated clinical questions using the PICO framework. Systematic searches of systematic reviews and, when considered appropriate, primary studies were conducted in three databases during 2023. Evidence was selected to address each clinical question. The certainty of the evidence (CoE) was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. Through periodic working meetings, the GDG formulated recommendations and good clinical practice (GCP) points based on a multicriteria analysis. The CPG was approved by Directorate Resolution No. 002-2024-CETS/INS. Results. The CPG addressed four clinical questions related to CRC screening. Based on these questions, six conditional recommendations were formulated (four in favor and two against), along with nine GCP points and one flowchart to guide decision-making in primary care. Key recommendations include suggesting against CRC screening in asymptomatic adults younger than 45 years without risk factors. In contrast, CRC screening is suggested for asymptomatic adults aged 45 to 75 years using the following test, depending on availability: annual or biennial fecal immunochemical test, annual or biennial faecal occult blood test, single flexible sigmoidoscopy, or single colonoscopy. However, in individuals with a 15-year CRC risk lower than 3%, an individualized decision-making process is suggested, considering patient preferences after being informed about the potential benefits and harms of screening. In asymptomatic adults older than 75 years, particularly those older than 80 years, CRC screening is not suggested. Finally, in asymptomatic adults with risk factors for CRC, CRC screening with any of the previously mentioned test is suggested. Conclusion. Evidence-based recommendations for colorectal cancer screening in primary care were developed and issued.